Onconic Therapeutics Inc. (KOSDAQ:476060)
21,250
-650 (-2.97%)
Apr 30, 2026, 3:30 PM KST
301.89% (1Y)
| Market Cap | 953.87B +257.8% |
| Revenue (ttm) | 53.39B +259.8% |
| Net Income | 15.78B |
| EPS | n/a |
| Shares Out | 44.89M |
| PE Ratio | 60.43 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 462,542 |
| Average Volume | 477,709 |
| Open | 21,800 |
| Previous Close | 21,900 |
| Day's Range | 20,600 - 21,800 |
| 52-Week Range | 5,000 - 28,900 |
| Beta | n/a |
| RSI | 45.84 |
| Earnings Date | Mar 20, 2026 |